Page last updated: 2024-11-01

niclosamide and Local Neoplasm Recurrence

niclosamide has been researched along with Local Neoplasm Recurrence in 3 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
"Oral Squamous Cell Carcinoma (OSCC) is one of the major causes of cancer related deaths worldwide."1.51CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma. ( Pindiprolu, SH; Pindiprolu, SKSS, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bansard, L1
Bouvet, O1
Moutin, E1
Le Gall, G1
Giammona, A1
Pothin, E1
Bacou, M1
Hassen-Khodja, C1
Bordignon, B1
Bourgaux, JF1
Prudhomme, M1
Hollande, F1
Pannequin, J1
Pascussi, JM1
Planque, C1
Rai, R1
Dey, DK1
Benbrook, DM1
Chandra, V1
Pindiprolu, SH1
Pindiprolu, SKSS1

Other Studies

3 other studies available for niclosamide and Local Neoplasm Recurrence

ArticleYear
Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy.
    Stem cell reports, 2022, 04-12, Volume: 17, Issue:4

    Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mice;

2022
Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 161

    Topics: Animals; Apoptosis; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female

2023
CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma.
    Medical hypotheses, 2019, Volume: 129

    Topics: AC133 Antigen; Apoptosis; Carcinoma, Squamous Cell; Drug Carriers; Drug Delivery Systems; Epithelial

2019